Search Results Search Sort by RelevanceMost Recent Case and Commentary Apr 2019 Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen’s Adherence? Constance E. George, MD, MA Ethical stakes include a psychiatrist’s care management responsibilities and burdens borne by family members over the course of the patient’s care. AMA J Ethics. 2019;21(4):E317-323. doi: 10.1001/amajethics.2019.317. Health Law Mar 2005 Must Doctors Report Underage Sex as Abuse? Kate Karas Virtual Mentor. 2005;7(3):234-238. doi: 10.1001/virtualmentor.2005.7.3.hlaw1-0503. State of the Art and Science Dec 2016 Locating Risk in the Adolescent Brain: Ethical Challenges in the Use of Biomarkers for Adolescent Health and Social Policy Suparna Choudhury, PhD and Sheehan Moore Neurobiological markers raise complex questions about what it means to be “at risk.” AMA J Ethics. 2016;18(12):1199-1206. doi: 10.1001/journalofethics.2016.18.12.stas1-1612. Viewpoint Mar 2005 Teenagers and Cosmetic Surgery Diana Zuckerman, PhD Virtual Mentor. 2005;7(3):253-256. doi: 10.1001/virtualmentor.2005.7.3.oped1-0503. Viewpoint Mar 2005 Ethics of Cosmetic Plastic Surgery in Adolescents Michael A. Bermant, MD Virtual Mentor. 2005;7(3):257-261. doi: 10.1001/virtualmentor.2005.7.3.oped2-0503. Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 1 Melissa D. Colsman, MA and David E. Sandberg, PhD Virtual Mentor. 2005;7(11):727-732. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511. Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 2 David B. Allen, MD Virtual Mentor. 2005;7(11):732-735. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511. Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 3 Wilma C. Rossi, MD, MBe, Virtual Mentor. 2005;7(11):735-738. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511. Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708. Policy Forum Aug 2008 Role of Independent Advocates for Research Subjects Who Are Child Wards of the State Hafzah Mueenuddin, JD and Eric D. Kodish, MD Specific advocate guidelines are needed for the protection of children in state custody who are potential research subjects in trials that would expose them to greater-than-minimal risk but also hold the prospect of direct benefit. Virtual Mentor. 2008;10(8):524-526. doi: 10.1001/virtualmentor.2008.10.8.pfor1-0808. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Case and Commentary Apr 2019 Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen’s Adherence? Constance E. George, MD, MA Ethical stakes include a psychiatrist’s care management responsibilities and burdens borne by family members over the course of the patient’s care. AMA J Ethics. 2019;21(4):E317-323. doi: 10.1001/amajethics.2019.317.
Health Law Mar 2005 Must Doctors Report Underage Sex as Abuse? Kate Karas Virtual Mentor. 2005;7(3):234-238. doi: 10.1001/virtualmentor.2005.7.3.hlaw1-0503.
State of the Art and Science Dec 2016 Locating Risk in the Adolescent Brain: Ethical Challenges in the Use of Biomarkers for Adolescent Health and Social Policy Suparna Choudhury, PhD and Sheehan Moore Neurobiological markers raise complex questions about what it means to be “at risk.” AMA J Ethics. 2016;18(12):1199-1206. doi: 10.1001/journalofethics.2016.18.12.stas1-1612.
Viewpoint Mar 2005 Teenagers and Cosmetic Surgery Diana Zuckerman, PhD Virtual Mentor. 2005;7(3):253-256. doi: 10.1001/virtualmentor.2005.7.3.oped1-0503.
Viewpoint Mar 2005 Ethics of Cosmetic Plastic Surgery in Adolescents Michael A. Bermant, MD Virtual Mentor. 2005;7(3):257-261. doi: 10.1001/virtualmentor.2005.7.3.oped2-0503.
Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 1 Melissa D. Colsman, MA and David E. Sandberg, PhD Virtual Mentor. 2005;7(11):727-732. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511.
Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 2 David B. Allen, MD Virtual Mentor. 2005;7(11):732-735. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511.
Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 3 Wilma C. Rossi, MD, MBe, Virtual Mentor. 2005;7(11):735-738. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511.
Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.
Policy Forum Aug 2008 Role of Independent Advocates for Research Subjects Who Are Child Wards of the State Hafzah Mueenuddin, JD and Eric D. Kodish, MD Specific advocate guidelines are needed for the protection of children in state custody who are potential research subjects in trials that would expose them to greater-than-minimal risk but also hold the prospect of direct benefit. Virtual Mentor. 2008;10(8):524-526. doi: 10.1001/virtualmentor.2008.10.8.pfor1-0808.